We recently attended two different NICE (National Institute for Health and Care Excellence) meetings on behalf of Dupuytren's disease patients.
There was a meeting to discuss the guidance for radiotherapy for Dupuytren’s disease which currently is limited. This means doctors can prescribe radiotherapy but it is not considered to be a regular treatment option. Anecdotally we know many patients who have seen improvements after radiotherapy so if you are considering it as a treatment option do get in touch for more advice.
There was also a meeting about Collagenase (Xiapex). Discussions are still ongoing and we await a final decision.